Intravitreal chemotherapy for intraocular lymphoma;Intravitreale chemotherapie bei okulozerebralem lymphom

Ophthalmologe

Volumn 100, Issue 2, 2003, Pages 145-149

  Helbig, H ^a   Cerny, Th ^a   De Smet, M D ^b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dexamethasone; Intraocular non hodgkin's lymphoma; Intravitreal chemotherapy; Methotrexate; Primary central nervous system lymphoma (PCNSL)

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; HUMAN; LYMPHOMA; NONHODGKIN LYMPHOMA; REVIEW; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR REGRESSION; VISION; ARTICLE; B CELL LYMPHOMA; BRAIN TUMOR; CASE REPORT; COMPARATIVE STUDY; EYE TUMOR; FEMALE; FOLLOW UP; INJECTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; TIME; VISUAL ACUITY; VITREOUS BODY;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DEXAMETHASONE; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; LYMPHOMA, B-CELL; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY DOSAGE; TIME FACTORS; VISUAL ACUITY; VITREOUS BODY;

EID: 0037673975     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-002-0692-z     Document Type: Review

References (34)

1. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859-63
2. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144-50
3. Cochereau-Massin I, Lehoang P, Lautier-Frau M et al. (1991) Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 98:1348-55
4. de Smet MD (2001) Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate. Bull Soc Belge Ophtalmol 91-5
5. de Smet MD, Stark-Vancs V, Kohler DR, Smith J, Wittes R, Nussenblatt RB (1996) Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol 121:442-4
6. de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC (1999) Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 83:448-51
7. DeAngelis LM (1999) Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 43:249-57
8. DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-43
9. Endophthalmitis Vitrectomy Study Group (1995) Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 113:1479-96
10. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA (1997) Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115:1152-6
11. Hainsworth DP, Pearson PA, Conklin JD, Ashton P (1996) Sustained release intravitreal dexamethasone. J Ocul Pharmacol Ther 12:57-63
12. Helbig H, Noske W, Kleineidam M, Kellner U, Foerster MH (1995) Bacterial endophthalmitis after anterior chamber paracentesis. Br J Ophthalmol 79:866
13. Homo-Delarche F (1984) Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review. Cancer Res 44:431-7
14. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425-7
15. Keizer HJ, Pinedo HM (1985) Cancer chemotherapy: alternative routes of drug administration. A review. Cancer Drug Deliv 2:147-69
16. Kishore K, Conway MD, Peyman GA (2001) Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 32:183-92
17. Kwak HW, D'Amico DJ (1992) Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol 110:259-66
18. Martin DF, Parks DJ, Mellow SD et al. (1994) Treatment of cytomegalovirus retinitis with an intraocular sustained- release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol 112:1531-9
19. Peyman GA, Schulman JA (1989) Intravitreal drug therapy. Jpn J Ophthalmol 33:392-404
20. Reni M, Ferreri AJ (2001) Therapeutic management of refractory or relapsed primary central nervous system lymphomas. Ann Hematol 80 [Suppl 3]:B113-7
21. Rohrbach JM, Zierhut M (2001) Intraokuläres (okulozerebrales) Non-Hodgkin-Lymphom. Ophthalmologe 98:495-505
22. Rootman J, Gudauskas G (1985) Treatment of ocular leukemia with local chemotherapy. Cancer Treat Rep 69:119-22
23. Ruhstaller TW, Amsler U, Cerny T (2000) Rituximab: active treatment of central nervous system involvement by non-Hodgkin's lymphoma? Ann Oncol 11:374-5
24. Sandor V, Stark-Vancs V, Pearson D, Nussenblat R, Whitcup SM, Brouwers P, Patronas N, Heiss J, Jaffe E, deSmet M, Kohler D, Simon R, Wittes R (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16:3000-6
25. Seregard S, Kock E, afTrampe E (1995) Intravitreal chemotherapy for recurrent retinoblastomain an only eye. Br J Ophthalmol 79:194-5
26. Shah GK, Stein JD, Sharma S et al. (2000) Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 107:486-9
27. Soussain C, Suzan F, Hoang-Xuan K et al. (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742-9
28. Velez G, Yuan P, Sung C et al. (2001) Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 119:1518-24
29. Whitcup SM, de Smet MD, Rubin BI et al. (1993) Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100:1399-406
30. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157-60
31. White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52:125-45
32. White VA, Gascoyne RD, Paton KE (1999) Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol 117:761-5
33. Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126:550-9
34. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29:2-6